FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208797984> ?p ?o ?g. }

• W3208797984 abstract "BackgroundUp-to-date seroprevalence estimates are critical to describe the SARS-CoV-2 immune landscape and to guide public health decisions.AimWe estimate seroprevalence of anti-SARS-CoV-2 antibodies 15 months into the COVID-19 pandemic and 6 months into the vaccination campaign.MethodsWe conducted a population-based cross-sectional serosurvey between 1 June and 7 July 2021, recruiting participants from age- and sex-stratified random samples of the general population. We tested participants for anti-SARS-CoV-2 antibodies targeting the spike (S) or nucleocapsid (N) proteins using the Roche Elecsys immunoassays. We estimated the anti-SARS-CoV-2 antibodies seroprevalence following vaccination and/or infection (anti-S antibodies), or infection only (anti-N antibodies).ResultsAmong 3,355 individuals (54.1% women; 20.8% aged < 18 years and 13.4% aged ≥ 65 years), 2,161 (64.4%) had anti-S antibodies and 906 (27.0%) had anti-N antibodies. The total seroprevalence was 66.1% (95% credible interval (CrI): 64.1-68.0). We estimated that 29.9% (95% Crl: 28.0-31.9) of the population developed antibodies after infection; the rest having developed antibodies via vaccination. Seroprevalence estimates differed markedly across age groups, being lowest among children aged 0-5 years (20.8%; 95% Crl: 15.5-26.7) and highest among older adults aged ≥ 75 years (93.1%; 95% Crl: 89.6-96.0). Seroprevalence of antibodies developed via infection and/or vaccination was higher among participants with higher educational level.ConclusionMost of the population has developed anti-SARS-CoV-2 antibodies, despite most teenagers and children remaining vulnerable to infection. As the SARS-CoV-2 Delta variant spreads and vaccination rates stagnate, efforts are needed to address vaccine hesitancy, particularly among younger individuals and to minimise spread among children." @default.
• W3208797984 created "2021-11-08" @default.
• W3208797984 creator A5000670406 @default.
• W3208797984 creator A5006379916 @default.
• W3208797984 creator A5009102950 @default.
• W3208797984 creator A5024739919 @default.
• W3208797984 creator A5025777567 @default.
• W3208797984 creator A5028324535 @default.
• W3208797984 creator A5029160541 @default.
• W3208797984 creator A5030134964 @default.
• W3208797984 creator A5030432467 @default.
• W3208797984 creator A5031808863 @default.
• W3208797984 creator A5038966793 @default.
• W3208797984 creator A5045788106 @default.
• W3208797984 creator A5053081343 @default.
• W3208797984 creator A5063284947 @default.
• W3208797984 creator A5064865817 @default.
• W3208797984 creator A5066697149 @default.
• W3208797984 creator A5073922153 @default.
• W3208797984 creator A5080804875 @default.
• W3208797984 creator A5081148623 @default.
• W3208797984 creator A5085000607 @default.
• W3208797984 creator A5087112771 @default.
• W3208797984 creator A5088304757 @default.
• W3208797984 creator A5090308781 @default.
• W3208797984 date "2021-10-28" @default.
• W3208797984 modified "2023-10-18" @default.
• W3208797984 title "Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021" @default.
• W3208797984 cites W3028456909 @default.
• W3208797984 cites W3031193631 @default.
• W3208797984 cites W3035189381 @default.
• W3208797984 cites W3084593143 @default.
• W3208797984 cites W3108096807 @default.
• W3208797984 cites W3108202535 @default.
• W3208797984 cites W3122043911 @default.
• W3208797984 cites W3127124856 @default.
• W3208797984 cites W3129344682 @default.
• W3208797984 cites W3158958041 @default.
• W3208797984 cites W3165803088 @default.
• W3208797984 cites W3165891573 @default.
• W3208797984 cites W3169503674 @default.
• W3208797984 cites W3176552995 @default.
• W3208797984 cites W3178680055 @default.
• W3208797984 cites W3187211318 @default.
• W3208797984 cites W3200259362 @default.
• W3208797984 cites W4205590514 @default.
• W3208797984 doi "https://doi.org/10.2807/1560-7917.es.2021.26.43.2100830" @default.
• W3208797984 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8555371" @default.
• W3208797984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34713799" @default.
• W3208797984 hasPublicationYear "2021" @default.
• W3208797984 type Work @default.
• W3208797984 sameAs 3208797984 @default.
• W3208797984 citedByCount "42" @default.
• W3208797984 countsByYear W32087979842022 @default.
• W3208797984 countsByYear W32087979842023 @default.
• W3208797984 crossrefType "journal-article" @default.
• W3208797984 hasAuthorship W3208797984A5000670406 @default.
• W3208797984 hasAuthorship W3208797984A5006379916 @default.
• W3208797984 hasAuthorship W3208797984A5009102950 @default.
• W3208797984 hasAuthorship W3208797984A5024739919 @default.
• W3208797984 hasAuthorship W3208797984A5025777567 @default.
• W3208797984 hasAuthorship W3208797984A5028324535 @default.
• W3208797984 hasAuthorship W3208797984A5029160541 @default.
• W3208797984 hasAuthorship W3208797984A5030134964 @default.
• W3208797984 hasAuthorship W3208797984A5030432467 @default.
• W3208797984 hasAuthorship W3208797984A5031808863 @default.
• W3208797984 hasAuthorship W3208797984A5038966793 @default.
• W3208797984 hasAuthorship W3208797984A5045788106 @default.
• W3208797984 hasAuthorship W3208797984A5053081343 @default.
• W3208797984 hasAuthorship W3208797984A5063284947 @default.
• W3208797984 hasAuthorship W3208797984A5064865817 @default.
• W3208797984 hasAuthorship W3208797984A5066697149 @default.
• W3208797984 hasAuthorship W3208797984A5073922153 @default.
• W3208797984 hasAuthorship W3208797984A5080804875 @default.
• W3208797984 hasAuthorship W3208797984A5081148623 @default.
• W3208797984 hasAuthorship W3208797984A5085000607 @default.
• W3208797984 hasAuthorship W3208797984A5087112771 @default.
• W3208797984 hasAuthorship W3208797984A5088304757 @default.
• W3208797984 hasAuthorship W3208797984A5090308781 @default.
• W3208797984 hasBestOaLocation W32087979841 @default.
• W3208797984 hasConcept C106192422 @default.
• W3208797984 hasConcept C126322002 @default.
• W3208797984 hasConcept C144024400 @default.
• W3208797984 hasConcept C149923435 @default.
• W3208797984 hasConcept C159654299 @default.
• W3208797984 hasConcept C203014093 @default.
• W3208797984 hasConcept C22070199 @default.
• W3208797984 hasConcept C2778494684 @default.
• W3208797984 hasConcept C2779134260 @default.
• W3208797984 hasConcept C2908647359 @default.
• W3208797984 hasConcept C3008058167 @default.
• W3208797984 hasConcept C45189115 @default.
• W3208797984 hasConcept C524204448 @default.
• W3208797984 hasConcept C71924100 @default.
• W3208797984 hasConcept C89623803 @default.
• W3208797984 hasConcept C99454951 @default.
• W3208797984 hasConceptScore W3208797984C106192422 @default.
• W3208797984 hasConceptScore W3208797984C126322002 @default.
• W3208797984 hasConceptScore W3208797984C144024400 @default.
• W3208797984 hasConceptScore W3208797984C149923435 @default.

• next